E1	Condition:T1 Name:T50
E2	Age:T2 Numeric-Filter:E3
E3	Eq-Comparison:T3 Value:T51 Operator:T52 Value:T53 Temporal-Unit:T54
E5	Eq-Comparison:T5 Temporal-Period:T55
E6	Procedure:T6 Temporality:E5
E7	Drug:T7 Name:T56
E9	Drug:T9 Name:T57
E10	Procedure:T10 Name:T58
E11	Condition:T11 
E12	Risk:T12 Polarity:T60 Risk-For:E15
E14	Risk:T14 Polarity:T61 Risk-For:E15
E15	Condition:T15 Name:T63 Acuteness:T62
E16	Condition:T16 Name:T65 Acuteness:T64
E17	Condition:T17 Name:T66
E18	Modifier:T18 Modifies:T67
E19	Condition:T19 Name:T67
E20	Condition:T20 Name:T68
E21	Condition:T21 Name:T69
E22	Condition:T22 Name:T70
E23	Age:T23 Numeric-Filter:E24
E24	Eq-Comparison:T24 Value:T72 Operator:T73 Value:T74 Temporal-Unit:T75
E25	Condition:T25 
E28	Condition:T28 
E29	Assertion:T29 Asserted:T77 Asserted2:T78
E31	Study:T31 Stability:T78
E32	Condition:T32 Name:T79
E35	Assertion:T35 Asserted:T81
E36	Observation:T36 Name:T27 Stability:T81
E37	Observation:T37 Specimen:T82
E39	Procedure:T39 Name:T33
E40	Condition:T40 Name:T83
E41	Eq-Comparison:T41 Temporal-Period:T84
E42	Procedure:T42 Name:T85 Temporality:E41
E43	Negation:T43 Negates:E42
E44	Condition:T44 Name:T86
E48	Condition:T48 Acuteness:T87 Acuteness:T47
E49	Negation:T49 Negates:E48
E50	Negation:T90 Negates:E18
E51	Negation:T91 Negates:E25 Negates2:E28
T1	Condition 35 41	cancer
T2	Age 52 55	age
T3	Eq-Comparison 56 66	1-18 years
T5	Eq-Comparison 75 83	received
T6	Procedure 94 103	treatment
T7	Drug 119 132	anthracycline
T9	Drug 140 156	alkylating agent
T10	Procedure 157 169	chemotherapy
T11	Condition 176 184	Diseases
T12	Risk 222 226	risk
T14	Risk 240 244	risk
T15	Condition 251 273	lymphoblastic leukemia
T16	Condition 281 297	myeloid leukemia
T17	Condition 299 315	Hodgkin lymphoma
T18	Modifier 321 328	Hodgkin
T19	Condition 329 337	lymphoma
T20	Condition 339 347	sarcomas
T21	Condition 349 356	Healthy
T22	Condition 369 376	Healthy
T23	Age 410 414	ages
T24	Eq-Comparison 415 425	1-18 years
T25	Condition 448 456	diseases
T28	Condition 460 478	medical conditions
T29	Assertion 484 492	might be
T31	Study 540 545	study
T32	Condition 547 554	Healthy
T35	Assertion 693 696	can
T36	Observation 708 728	epigenetic signature
T37	Observation 779 784	blood
T39	Procedure 808 820	routine care
T40	Condition 842 848	Cancer
T41	Eq-Comparison 880 888	received
T42	Procedure 891 913	bone marrow transplant
T43	Negation 919 922	not
T44	Condition 936 943	Healthy
T47	Acuteness 1048 1055	chronic
T48	Condition 1056 1063	disease
T49	Negation 1072 1080	excluded
T50	Condition-Name 35 41	cancer
T51	Eq-Value 56 57	1
T52	Eq-Operator 57 58	-
T53	Eq-Value 58 60	18
T54	Eq-Temporal-Unit 61 66	years
T55	Eq-Temporal-Period 75 83	received
T56	Drug-Name 119 132	anthracycline
T57	Drug-Name 140 156	alkylating agent
T58	Procedure-Name 157 169	chemotherapy
T60	Polarity 217 221	high
T61	Polarity 235 239	high
T62	Acuteness 245 250	acute
T63	Condition-Name 251 273	lymphoblastic leukemia
T64	Acuteness 275 280	acute
T65	Condition-Name 281 297	myeloid leukemia
T66	Condition-Name 299 315	Hodgkin lymphoma
T67	Condition-Name 329 337	lymphoma
T68	Condition-Name 339 347	sarcomas
T69	Condition-Name 349 356	Healthy
T70	Condition-Name 369 376	Healthy
T71	Life-Stage-And-Gender 401 409	children
T72	Eq-Value 415 416	1
T73	Eq-Operator 416 417	-
T74	Eq-Value 417 419	18
T75	Eq-Temporal-Unit 420 425	years
T76	Condition-Name 448 456	diseases
T77	Stability 493 501	affected
T78	Stability 516 522	impact
T79	Condition-Name 547 554	Healthy
T81	Stability 697 703	affect
T82	Specimen 779 784	blood
T83	Condition-Name 842 848	Cancer
T84	Eq-Temporal-Period 880 888	received
T85	Procedure-Name 891 913	bone marrow transplant
T86	Condition-Name 936 943	Healthy
T87	Acuteness 1039 1044	acute
T89	Life-Stage-And-Gender 25 34	Childhood
T90	Negation 317 320	non
T91	Negation 438 447	free from
T27	Observation-Name 708 728	epigenetic signature
T33	Procedure-Name 808 820	routine care
A1	Assertion-Type-Value E29 hypothetical
A3	Assertion-Type-Value E35 hypothetical
A4	Eq-Operator-Value T52 BETWEEN
A5	Eq-Temporal-Unit-Value T54 year
A6	Eq-Temporal-Period-Value T55 past
A7	Polarity-Value T60 high
A8	Polarity-Value T61 high
A11	Life-Stage-And-Gender-Type T71 child
A12	Eq-Operator-Value T73 BETWEEN
A13	Eq-Temporal-Unit-Value T75 year
A14	Stability-Value T77 change
A15	Stability-Value T78 change
A16	Stability-Value T81 change
A17	Eq-Temporal-Period-Value T84 past
A19	Life-Stage-And-Gender-Type T89 child
A20	Acuteness-Type-Value T62 acute
A21	Acuteness-Type-Value T64 acute
A22	Acuteness-Type-Value T87 acute
A23	Acuteness-Type-Value T47 chronic
R1	Using Arg1:E6 Arg2:E7
R2	Using Arg1:E10 Arg2:E7
R3	Using Arg1:E10 Arg2:E9
R4	Example-Of Arg1:E15 Arg2:E11
R5	Example-Of Arg1:E16 Arg2:E11
R6	Example-Of Arg1:E17 Arg2:E11
R7	Example-Of Arg1:E19 Arg2:E11
R8	Example-Of Arg1:E20 Arg2:E11
R9	Equivalent-To Arg1:T71 Arg2:E22
R10	Caused-By Arg1:T78 Arg2:E25
R11	Caused-By Arg1:T78 Arg2:E28
R12	Using Arg1:E39 Arg2:E37
R13	Or Arg1:E7 Arg2:E9
R14	Or Arg1:E12 Arg2:E14
R15	Or Arg1:E25 Arg2:E28
R16	Or Arg1:T77 Arg2:T78
R17	Or Arg1:T87 Arg2:T47
R18	And Arg1:E2 Arg2:E6
R19	And Arg1:E23 Arg2:E51
R20	Or Arg1:E16 Arg2:E17
R21	Or Arg1:E19 Arg2:E20
